202493
Media An article by COO Kikuo Yasui on Japan's drug discovery ecosystem has been published in "BioSpectrum Asia".
2024731
Congress Heartseed CMO Dr. Takehiko Kaneko to Speak at the 3rd Heart Failure Drug Discovery & Development Summit in Boston
2024730
PR Heartseed Announces Positive Recommendation from Safety Monitoring Committee for Dose Escalation in Phase 1/2 Clinical Trial Dosed With HS-001
202458
Congress Initial Results of the LAPiS Trial with HS-001 to Be Presented at the 2024 European Society of Cardiology - Heart Failure Congress
202452
PR Heartseed.'s CFO, Mutsuki Takano, Named "Most Innovative CFO from Asia to Watch in 2024" by CXO Magazine